453.html
Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerations
Chamber (453)
§§ 453-475h
10.5840/inquiryctnews1993123/453
Safety and efficacy of a feed additive consisting of l‐lysine monohydrochloride produced with Corynebacterium glutamicum CGMCC 7.453 for all animal species (Eppen Europa SAS)
Museum (453)
N. 453
声 (453)
453. Charles Ollier